About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Team (14)
Alan Glicklich
Alan Glicklich, M.D
CalciMedica
team_member
Allan L
Allan L. Shaw
CalciMedica
team_member
Andrew (Andy) Cunningham
Andrew (Andy) Cunningham, M.D., MRCPI
CalciMedica
team_member
Eric W
Eric W. Roberts
CalciMedica
team_member
Fred Guerard
Fred Guerard, PharmD
CalciMedica
team_member
Fred Middleton
Fred Middleton, MBA
CalciMedica
team_member
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
759
By Phase
PHASE2: 7PHASE1/PHASE2: 1
By Status
COMPLETED: 5RECRUITING: 2WITHDRAWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06374797Lead Sponsor
"A Study of Auxora in Patients With AKI and Injurious Lung Crosstalk"
PHASE2Recruiting
150 participants
Started: Jul 1, 2024 · Completed: Mar 31, 2026
NCT05171920Lead Sponsor
A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia
PHASE2Withdrawn
Started: Jan 24, 2022 · Completed: Jul 31, 2022
NCT04681066Lead Sponsor
A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS
PHASE2Completed
216 participants
Started: Mar 24, 2021 · Completed: May 15, 2024
NCT04661540Lead Sponsor
A Study of Auxora in Patients With Critical COVID-19 Pneumonia
PHASE2Completed
9 participants
Started: Mar 2, 2021 · Completed: Nov 2, 2021
NCT04195347Collaborator
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
PHASE1/PHASE2Recruiting
42 participants
Started: Sep 4, 2020 · Completed: Dec 31, 2027
Locations (1)
Headquarters
La Jolla, CA, United States
Map
Loading map...